{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:14:14Z","timestamp":1760177654378,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ecl.2006.11.012","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T12:46:45Z","timestamp":1172839605000},"page":"203-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Management of Adult Growth Hormone Deficiency"],"prefix":"10.1016","volume":"36","author":[{"given":"Gudmundur","family":"Johannsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2006.11.012_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular diseases in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.11.012_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.11.012_bib3","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.11.012_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effect of growth hormone treatment in GH-deficient adults","volume":"i","author":"J\u00f8rgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.11.012_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2265.1994.tb02583.x","article-title":"The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism","volume":"41","author":"Toogood","year":"1994","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/edrv.19.2.0329","article-title":"The diagnosis of growth hormone deficiency in children and adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2006.11.012_bib8","first-page":"379","article-title":"Invited report of a workshop. Consensus guidelines for the diagnosis of growth hormone deficiency: summary statement of the Growth Hormone Research Society workshop on adult growth hormone deficiency","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2265.1997.1851001.x","article-title":"Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test","volume":"46","author":"Svensson","year":"1997","journal-title":"Clin Endocrinol [Oxf]"},{"issue":"5","key":"10.1016\/j.ecl.2006.11.012_bib10","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency","volume":"87","author":"Biller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.140.3570.987","article-title":"Hypoglycemia: potent stimulus to secretion of growth hormone","volume":"140","author":"Roth","year":"1963","journal-title":"Science"},{"key":"10.1016\/j.ecl.2006.11.012_bib12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","article-title":"Diagnosis of growth hormone deficiency in adults","volume":"343","author":"Hoffman","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ecl.2006.11.012_bib13","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1210\/jcem-70-5-1361","article-title":"Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects","volume":"70","author":"Cordido","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2006.11.012_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/eje.0.1330305","article-title":"Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test","volume":"133","author":"Hoeck","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2006.11.012_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1994.tb03793.x","article-title":"An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year","volume":"41","author":"Jones","year":"1994","journal-title":"Clin Endocrinol [Oxf]"},{"issue":"3","key":"10.1016\/j.ecl.2006.11.012_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1530\/eje.0.1340352","article-title":"New approach to the diagnosis of growth hormone deficiency in adults","volume":"134","author":"Ghigo","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2006.11.012_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2006.11.012_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/jc.2002-021094","article-title":"The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval","volume":"88","author":"Darzy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"9236","key":"10.1016\/j.ecl.2006.11.012_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(00)02755-0","article-title":"GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults","volume":"356","author":"Popovic","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.11.012_bib20","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and the treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society","volume":"85","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.1994.tb01830.x","article-title":"The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults","volume":"41","author":"Weaver","year":"1994","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-69-6-1127","article-title":"Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism","volume":"69","author":"J\u00f8rgensen","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib23","doi-asserted-by":"crossref","first-page":"E1191","DOI":"10.1152\/ajpendo.2001.281.6.E1191","article-title":"Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women","volume":"281","author":"Wolthers","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2006.11.012_bib24","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2005-0553","article-title":"Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men","volume":"90","author":"Johannsson","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1995.tb01908.x","article-title":"Which adults develop side-effects of growth hormone replacement?","volume":"43","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib26","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women","volume":"82","author":"Burman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib27","first-page":"2877","article-title":"Two years of growth hormone (GH) treatment increases isometric and isokinetic muscle strength in GH-deficient adults","volume":"82","author":"Johannsson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib28","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/01.ATV.15.12.2142","article-title":"Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults: influence of gender and apo(a) and apoE phenotypes","volume":"15","author":"Johannsson","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ecl.2006.11.012_bib29","first-page":"464","article-title":"A switch from oral (2 mg\/day) to transdermal (50 microg\/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency","volume":"85","author":"Janssen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib30","first-page":"1575","article-title":"The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH binding protein, body mass index, age and gender","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib32","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","article-title":"Opimizing growth hormone replacement therapy by dose titration in hypopituitary adults","volume":"83","author":"Drake","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1994.tb02556.x","volume":"41","author":"Landin-Wilhelmsen","year":"1994","journal-title":"Clin Endocrinol [Oxf]"},{"issue":"5","key":"10.1016\/j.ecl.2006.11.012_bib34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2265.2000.00971.x","article-title":"Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency","volume":"52","author":"Murray","year":"2000","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib35","first-page":"1371","article-title":"Monitoring of growth hormone replacement therapy in adults, based on measurements of serum markers","volume":"81","author":"de Boer","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib36","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.96.12.7088","article-title":"Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice","volume":"96","author":"Sj\u00f6gren","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.ecl.2006.11.012_bib37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/diabetes.50.7.1539","article-title":"Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism","volume":"50","author":"Sjogren","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2006.11.012_bib38","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jcem.87.4.8394","article-title":"GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis","volume":"87","author":"Johannsson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib39","first-page":"1868","article-title":"Consensus. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib40","first-page":"2069","article-title":"The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis","volume":"80","author":"de Boer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib41","first-page":"1070","article-title":"The effects of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study","volume":"79","author":"Valk","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib42","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1210\/jcem.87.7.8593","article-title":"Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients","volume":"87","author":"Attanasio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib43","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety","volume":"50","author":"Abs","year":"1999","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2265.1996.00820.x","article-title":"Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults: preliminary data from a small group of patients","volume":"45","author":"Johannsson","year":"1996","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.1999.00838.x","article-title":"Influences on quality of life in GH deficient adults and their effect on response to treatment","volume":"51","author":"Murray","year":"1999","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.1998.00462.x","article-title":"Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency","volume":"48","author":"Wir\u00e9n","year":"1998","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.ecl.2006.11.012_bib48","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone-deficient adults are insulin-resistant","volume":"44","author":"Johansson","year":"1995","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.ecl.2006.11.012_bib49","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults","volume":"87","author":"Svensson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2006.11.012_bib50","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices","volume":"86","author":"Gotherstrom","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9216","key":"10.1016\/j.ecl.2006.11.012_bib51","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(05)73137-8","article-title":"Can growth hormone therapy cause diabetes? KIMS Strategic Committee","volume":"355","author":"Monson","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ecl.2006.11.012_bib52","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib53","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2006.11.012_bib54","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1359\/JBMR.050613","article-title":"Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men","volume":"20","author":"Bravenboer","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.ecl.2006.11.012_bib55","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/jcem.86.10.7896","article-title":"Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study","volume":"86","author":"Koranyi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2006.11.012_bib56","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1359\/jbmr.2002.17.6.1081","article-title":"The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial","volume":"17","author":"Bex","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2006.11.012_bib57","first-page":"2865","article-title":"Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1152\/jappl.1991.70.2.688","article-title":"Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1016\/j.ecl.2006.11.012_bib59","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2002-020901","article-title":"Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength","volume":"88","author":"Svensson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment","volume":"355","author":"Cutfield","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.11.012_bib61","first-page":"453","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2006.11.012_bib62","first-page":"3762","article-title":"Effects of 7 years of growth hormone replacement therapy in hypopituitary adults","volume":"85","author":"Chrisoulidou","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2006.11.012_bib63","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib64","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group","volume":"49","author":"Popovic","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.11.012_bib65","first-page":"1420","article-title":"Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality","volume":"85","author":"Nilsson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib66","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2000.18.4.847","article-title":"Hormonal predictors of prostate cancer: A meta-analysis","volume":"18","author":"Shaneyfelt","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ecl.2006.11.012_bib67","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.11.012_bib68","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","article-title":"Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3","volume":"91","author":"Ma","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl A","key":"10.1016\/j.ecl.2006.11.012_bib69","first-page":"3","article-title":"Effects of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency","volume":"3","author":"Johannsson","year":"1996","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas","volume":"38","author":"Brada","year":"1993","journal-title":"Clin Endocrinol [Oxf]"},{"issue":"11","key":"10.1016\/j.ecl.2006.11.012_bib71","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1210\/jcem.86.11.8018","article-title":"Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy","volume":"86","author":"Frajese","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2006.11.012_bib72","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol [Oxf]"},{"issue":"6","key":"10.1016\/j.ecl.2006.11.012_bib73","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2005.02282.x","article-title":"Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors","volume":"62","author":"Jostel","year":"2005","journal-title":"Clin Endocrinol [Oxf]"},{"issue":"3","key":"10.1016\/j.ecl.2006.11.012_bib74","first-page":"872","article-title":"Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes","volume":"79","author":"Brismar","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib75","first-page":"27","article-title":"A human placental GH: increasing levels during second half of pregnancy with pituitary GH suppression as revealed by monoclonal antibody radioimmunoassays","volume":"30","author":"Hennen","year":"1985","journal-title":"Int J Fertil"},{"key":"10.1016\/j.ecl.2006.11.012_bib76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/eje.0.1420353","article-title":"Growth hormone isoforms in newborns and postpartum women","volume":"142","author":"Boguszewski","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2006.11.012_bib77","first-page":"E1014","article-title":"Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy","volume":"258","author":"Caufriez","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ecl.2006.11.012_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0303-7207(98)00039-2","article-title":"Fetal growth and placental function","volume":"140","author":"Bauer","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ecl.2006.11.012_bib79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1210\/jcem-59-4-587","article-title":"Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency","volume":"59","author":"Hall","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.11.012_bib80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2265.2002.01572.x","article-title":"Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy","volume":"57","author":"Wiren","year":"2002","journal-title":"Clin Endocrinol [Oxf]"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:28:05Z","timestamp":1760174885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852906001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0889852906001034"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2006.11.012","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Adult Growth Hormone Deficiency","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2006.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}